AUR300 - Aurinia Pharma
bleomycin - Generic mfg.
Evaluation of a CD206-Targeted Peptide for PET Imaging of Macrophages in Syngeneic Mouse Models of Cancer. (PubMed, Mol Pharm) - Apr 5, 2023 - "In addition, it has shown inhibition in bleomycin-induced pulmonary fibrosis through interactions with CD206 macrophages. A significant correlation was found between the percentage of CD206 present in each tumor imaged with [Ga]RP832c and PET imaging mean standardized uptake values in a CT26 mouse model of cancer. The data shows that [Ga]RP832c represents a promising candidate for macrophage imaging in cancer and other diseases." 
Journal • Preclinical • Fibrosis • Idiopathic Pulmonary Fibrosis • Immunology • Melanoma • Oncology • Pulmonary Disease • Respiratory Diseases • Solid Tumor • MRC1
http://www.ncbi.nlm.nih.gov/pubmed/37014648
 
Apr 5, 2023
 
Prev Next